N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 13 ((3'r)-1'-{5-amino-1-[(2s)-1,1,1-trifluorobutan-2-yl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one)
PDB DOI: 10.2210/pdb10qs/pdb
Classification: HYDROLASE/INHIBITOR Organism(s): Homo Sapiens
Deposited: 2026-02-02 Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , He, J. , Hicks, J. , Hruza, A. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogowa, A. , Piou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yany, S.
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 13 ((3'r)-1'-{5-amino-1-[(2s)-1,1,1-trifluorobutan-2-yl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one)
Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , He, J. , Hicks, J. , Hruza, A. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogowa, A. , Piou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yany, S.
Primary Citation of Related Structures: 10QS
| Proteins | ||||
|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Sequence |
| Plasma kallikrein | A | 275 | Homo Sapiens | KREAEANTGDNSVSTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPAHHHHHH |
Method: X-RAY DIFFRACTION
Deposited Date: 2026-02-02 Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , He, J. , Hicks, J. , Hruza, A. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogowa, A. , Piou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yany, S.